Shire PLC (LON:SHP) was downgraded by investment analysts at Barclays PLC to an “equal weight” rating in a report released on Friday.

Other equities analysts have also recently issued reports about the stock. Goldman Sachs Group, Inc. (The) reiterated a “buy” rating and set a GBX 6,800 ($88.55) target price on shares of Shire PLC in a research note on Wednesday, May 3rd. Shore Capital reiterated a “buy” rating on shares of Shire PLC in a research note on Monday, April 24th. Liberum Capital reiterated a “buy” rating and set a GBX 5,500 ($71.62) target price on shares of Shire PLC in a research note on Wednesday, May 3rd. Deutsche Bank AG reiterated a “buy” rating and set a GBX 6,300 ($82.04) target price on shares of Shire PLC in a research note on Wednesday, May 3rd. Finally, Jefferies Group LLC reiterated a “buy” rating and set a GBX 6,400 ($83.34) target price on shares of Shire PLC in a research note on Wednesday, May 3rd. Four research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of GBX 5,937.29 ($77.32).

Shares of Shire PLC (SHP) opened at 3876.50 on Friday. The company’s market cap is GBX 35.14 billion. Shire PLC has a 52-week low of GBX 3,873.00 and a 52-week high of GBX 5,377.00. The stock has a 50 day moving average of GBX 4,234.98 and a 200 day moving average of GBX 4,527.34.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/shire-plc-lonshp-downgraded-by-barclays-plc/1471427.html.

In other news, insider Dominic Blakemore bought 152 shares of the company’s stock in a transaction that occurred on Friday, June 30th. The stock was acquired at an average price of GBX 4,255 ($55.41) per share, for a total transaction of £6,467.60 ($8,422.45).

About Shire PLC

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Analyst Recommendations for Shire PLC (LON:SHP)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.